Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0615-8660

2 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0615-8660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Acamprosate 8660 1)

Structure.jpg (Acamprosate 8660 1)
Chemical structure of Acamprosate Calcium showing its molecular components, including carboxyl groups, amide linkages, and sulfonate groups coordinated with calcium ions.*
FDA Label Image

Principal Display Panel (Acamprosate 8660 2)

Principal Display Panel (Acamprosate 8660 2)
Label for Acamprosate Calcium Delayed-Release Tablets 333 mg, oral tablet by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes lot number 8660, quantity 30 tablets, and storage instructions. It shows multiple barcode labels for institutional use, with packaging by Vangard, Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.